Reviewing Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) & ReWalk Robotics (NASDAQ:LFWD)

Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) and ReWalk Robotics (NASDAQ:LFWD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.

Valuation & Earnings

This table compares Shandong Weigao Group Medical Polymer and ReWalk Robotics’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shandong Weigao Group Medical Polymer	$2.02 billion	N/A	$404.68 million	N/A	N/A
ReWalk Robotics	$13.85 million	2.92	-$22.13 million	($2.87)	-1.66

Shandong Weigao Group Medical Polymer has higher revenue and earnings than ReWalk Robotics.

Profitability

This table compares Shandong Weigao Group Medical Polymer and ReWalk Robotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shandong Weigao Group Medical Polymer	N/A	N/A	N/A
ReWalk Robotics	-159.76%	-28.19%	-23.29%

Insider & Institutional Ownership

26.8% of ReWalk Robotics shares are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Shandong Weigao Group Medical Polymer and ReWalk Robotics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shandong Weigao Group Medical Polymer	0	0	1	0	3.00
ReWalk Robotics	0	0	1	0	3.00

ReWalk Robotics has a consensus price target of $9.00, indicating a potential upside of 89.47%. Given ReWalk Robotics’ higher possible upside, analysts clearly believe ReWalk Robotics is more favorable than Shandong Weigao Group Medical Polymer.

Risk & Volatility

Shandong Weigao Group Medical Polymer has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 2, suggesting that its share price is 100% more volatile than the S&P 500.

Summary

Shandong Weigao Group Medical Polymer beats ReWalk Robotics on 5 of the 9 factors compared between the two stocks.

About Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, specialized single-use clinical collection kits, digital products for clinical care, digestive nutrition, and primary care products; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, open and minimally invasive surgical equipment, wound healing dressings, wound suture, wound cleaning, and nonvascular catheter supporting extracorporeal devices. It also provides blood collection, irradiation, storage, separation, and sterilization products; blood collection and blood glucose testing devices; trauma, spinal implant, artificial joints, sports injury, soft tissue repair, reconstruction implant, orthopedic filling, and orthopedic related surgical tools; tumor intervention, vascular intervention, and interventional imaging; and prefilled syringes and pre-filled flush syringes. In addition, the company engages in the manufacturing of implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and X-ray based irradiation machines. Further, it is involved in the finance leasing and factoring business; provision of asset management, enterprise consulting, enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.